Thyroid hormones and thyroid hormone sensitivity indices correlate with volumetric bone mineral density and vertebral fracture risk among the osteoporotic population in northern China - Scorecard - MDSpire

Thyroid hormones and thyroid hormone sensitivity indices correlate with volumetric bone mineral density and vertebral fracture risk among the osteoporotic population in northern China

  • By

  • Zhou Meicen

  • Deng Wei

  • Wang Yanai

  • Huo Lili

  • Gao Tan

  • Chen Jia

  • June 4, 2026

  • 0 min

Share

Clinical Scorecard: Associations Between Thyroid Hormones, Sensitivity Indices, Volumetric Bone Mineral Density, and Vertebral Fracture Risk in Osteoporotic Individuals in Northern China

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPrimary osteoporotic individuals aged over 50 years with euthyroidism in northern China.
Care Setting

Key Highlights

  • highlight_5

Guideline-Based Recommendations

Diagnosis

    Management

    • Monitor thyroid hormone levels and their sensitivity indices (FT4/FT3, TSHI, TT4RI) in relation to bone health.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Thyroid hormone levels may serve as indicators for fracture risk and bone mass, guiding treatment decisions.

        Clinical Best Practices

        • best_practice_1

        Related Resources & Content

        Original Source(s)

        Thyroid hormones and thyroid hormone sensitivity indices correlate with volumetric bone mineral density and vertebral fracture risk among the osteoporotic population in northern China

        • by Zhou Meicen, Deng Wei, Wang Yanai, Huo Lili, Gao Tan, Chen Jia

        • June 4, 2026

        Related Content

        Association of Bone Mass, Falls, and Vertebral Fractures in Older Patients on Hemodialysis: The Role of Comprehensive Geriatric Assessment

        Associations of FGF23 and Apelin-13 with osteoporosis and diabetic peripheral neuropathy in postmenopausal women with type 2 diabetes mellitus

        Uridine Suppresses ROS-Driven Osteoclast Differentiation and Mitigates Osteoporosis Through PI3K/Akt–FoxO Pathway Modulation